Prescription Drugs
Pharma Pipelines, by the Numbers
3/28/13
Europe’s pharma pipeline disclosure is more detailed than in the U.S., where drugs in phase I trials are not always disclosed. This means counting the total number of drugs in development is more accurate in Europe.

Read More:

from Bloomberg BusinessWeek,
3/28/13:



365 Days Page
Comment ( 0 )
Leave a Reply
Name*
E-mail*
Comment